FINWIRES · TerminalLIVE
FINWIRES

Research Alert: Icici Bank: Broadly Better-than-expected Fy 26 Results

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

FY 26 (Mar.) EPADS rose 5.1% to INR149.54, beating our flattish estimate due to better-than-projected loan growth (+15.8%; of which, business banking: +24.4%; retail and corporate loans: +9% to +10%), NIM (stable at 4.32%), and non-banking income. We think robust demand from SMEs, the positive impact of the 0%-GST reform in September 2025 on consumer spending, and the strong housing market will sustain loan momentum into FY 27. We see some pressure on NIM from the 25-bp cut in the benchmark repo rate in December 2025, but expect ICICI's NIM to stay range-bound and industry leading, aided by faster growth in higher-yielding business loans and ICICI's relatively high mix of CASA deposits (at about 41.4% of total deposits at end-FY 26). Asset quality was solid. Provision charges rose 14.9% in FY 26 due to an additional standard asset provision set aside for agricultural priority sector credit facilities, but there is no change in the portfolio's asset quality. We expect provision charges to ease in FY 27.

Related Articles

Asia

Shakti Pumps (India) Invests INR100 Million in EV Mobility Unit

Shakti Pumps (India) (NSE:SHAKTIPUMP, BOM:531431) said it has invested 100 million Indian rupees in its wholly owned subsidiary Shakti EV Mobility by subscribing to 10 million equity shares, according to a Tuesday filing to the Indian stock exchanges.Shares of the company rose 1% in Wednesday's trade.With this, Shakti Pumps' total investment in the EV mobility unit has increased to 650 million Indian rupees, the filing said.The investment is aimed at supporting business expansion of the subsidiary, it added.

$BOM:531431$NSE:SHAKTIPUMP
Asia

Challenger's Fiscal 2026 Q3 Update Missed Consensus Across Key Life Metrics, Jarden Says

Challenger's (ASX:CGF) fiscal 2026 third-quarter update missed consensus across key Life metrics, with FM outflows significantly worse than expected, driven by institutional equity mandate attrition in both Australian and global equities, according to a Tuesday note by Jarden.The firm's redemption of all CGFPC notes on May 25 simplifies the capital structure, reduces the AT1 coupon burden, and is earnings-per-share accretive.Jarden sees balanced risk/reward for Challenger in the future, with catalysts including capital management flexibility from the Australian Prudential Regulation Authority reform, as well as expanding retirement partnerships across superfunds.It lowered its fiscal 2026 sales forecast to reflect weaker institutional fixed-term sales, partially offset by higher retail annuity sales as partnerships come online.The investment firm retained its neutral rating on Challenger and raised the price target to AU$8.70 per share from AU$8.60 per share.

$ASX:CGF
Asia

Proya Cosmetics 2025 Profit Down 4%, Revenue Slips 2%

Proya Cosmetics (SHA:603605) posted 2025 attributable net profit of 1.50 billion yuan, down 3.5% from 1.55 billion yuan the previous year.Earnings per share slid to 3.80 yuan from 3.92 yuan, according to a Wednesday filing with the Shanghai bourse.Operating revenue declined 1.7% year over year to 10.6 billion yuan from 10.8 billion yuan.Shares of the cosmetics maker were up over 1% in recent trade.

$SHA:603605